Emerging evidence suggested that inhibition of ileal FXR-FGF15 induced beneficial effects that can lead to the improvement of non-alcoholic fatty liver disease (NAFLD), obesity, and insulin resistance12–14. The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.